文献速递角膜与眼表疾病

复杂多样性的悖论:细菌性角膜炎诊断与管理的挑战

Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis.
PubMed 文献 · Prog Retin Eye Res · 2021-11-20

细菌性角膜炎仍是发达国家和发展中国家角膜盲的主要原因之一。本文综述了细菌性角膜炎的已有诊断技术和治疗方法,报告了准确诊断单菌和混合细菌性角膜感染的新工具进展,概述了导致抗生素耐药的亚细胞基因组变化,并讨论了正在开发的新疗法和药物递送系统。

要点

  • 细菌性角膜炎仍是角膜盲的主要原因,尽管抗生素时代以来已有快速进展。
  • 知识缺口阻碍了早期准确诊断和管理,导致临床结局不佳。
  • 细菌通过大基因组编码复杂调控网络、独特毒力因子及快速分泌组织损伤性蛋白酶和毒素来应对治疗挑战。

核心结论

  • 细菌性角膜炎仍是发达国家和发展中国家角膜盲的主要原因之一。
  • 尽管对致病微生物和相关病理的认识快速发展,但知识缺口仍阻碍早期准确诊断和管理,导致临床结局不佳。

研究设计与样本

  • 综述文章,概述细菌性角膜炎的已有诊断技术和治疗方法,并报告新工具和新疗法进展。

主要发现

  • 细菌通过大基因组编码复杂调控网络、多种独特毒力因子以及快速分泌组织损伤性蛋白酶和毒素来应对治疗挑战。
  • 综述报告了准确诊断单菌和混合细菌性角膜感染的新工具进展。
  • 综述概述了作者团队及其他团队在理解导致抗生素耐药的亚细胞基因组变化方面的进展。
  • 综述详细讨论了正在开发的新疗法和药物递送系统。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bacterial keratitis continues to be one of the leading causes of corneal blindness in the developed as well as the developing world, despite swift progress since the dawn of the "anti-biotic era". Although, we have expeditiously developed our understanding about the different causative organisms and associated pathology leading to keratitis, extensive gaps in knowledge continue to dampen the efforts required for early and accurate diagnosis, and management in these patients, resulting in poor clinical outcomes. The ability of the causative bacteria to subdue the therapeutic challenge stems from their large genome encoding complex regulatory networks, variety of unique virulence factors, and rapid secretion of tissue damaging proteases and toxins. In this review article, we provide an overview of the established diagnostic techniques and therapeutics for keratitis caused by various bacteria. We extensively report the recent in-roads through novel tools for accurately diagnosing mono- and poly-bacterial corneal infections. Furthermore, we outline the recent progress by our groups and others in understanding the sub-cellular genomic changes that lead to antibiotic resistance in these organisms. Finally, we discuss in detail, the novel therapies and drug delivery systems in development for the efficacious management of bacterial keratitis.

来源:Prog Retin Eye Res,查看原文。版权归原作者所有。

引用

  1. Singh RB, Das S, Chodosh J, et al. Paradox of complex diversity: Challenges in the diagnosis and management of bacterial keratitis. Prog Retin Eye Res. 2021. PMID: 34813978. doi:10.1016/j.preteyeres.2021.101028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。